Literature DB >> 31570540

Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy.

John S Gill1,2, Richard N Formica3, Josh Levitsky4.   

Abstract

Keywords:  HCV donor; kidney; transplantation

Mesh：

Year:  2019        PMID： 31570540      PMCID： PMC6779353          DOI： 10.1681/ASN.2019070726

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  4 in total

1.  Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.

Authors:  David S Goldberg; Peter L Abt; Emily A Blumberg; Vivianna M Van Deerlin; Matthew Levine; K Rajender Reddy; Roy D Bloom; Susanna M Nazarian; Deirdre Sawinski; Paige Porrett; Ali Naji; Richard Hasz; Lawrence Suplee; Jennifer Trofe-Clark; Anna Sicilia; Maureen McCauley; Midhat Farooqi; Caren Gentile; Jennifer Smith; Peter P Reese
Journal:  N Engl J Med       Date:  2017-04-30       Impact factor: 91.245

2.  National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.

Authors:  Vishnu S Potluri; David S Goldberg; Sumit Mohan; Roy D Bloom; Deirdre Sawinski; Peter L Abt; Emily A Blumberg; Chirag R Parikh; James Sharpe; K Rajender Reddy; Miklos Z Molnar; Meghan Sise; Peter P Reese
Journal:  J Am Soc Nephrol       Date:  2019-09-12       Impact factor: 10.121

3.  The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.

Authors:  J Levitsky; R N Formica; R D Bloom; M Charlton; M Curry; J Friedewald; J Friedman; D Goldberg; S Hall; M Ison; T Kaiser; D Klassen; G Klintmalm; J Kobashigawa; A Liapakis; K O'Conner; P Reese; D Stewart; N Terrault; N Theodoropoulos; J Trotter; E Verna; M Volk
Journal:  Am J Transplant       Date:  2017-07-01       Impact factor: 8.086

4.  Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

Authors:  Christine M Durand; Mary G Bowring; Diane M Brown; Michael A Chattergoon; Guido Massaccesi; Nichole Bair; Russell Wesson; Ashraf Reyad; Fizza F Naqvi; Darin Ostrander; Jeremy Sugarman; Dorry L Segev; Mark Sulkowski; Niraj M Desai
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 51.598
  4 in total
  1 in total

1.  Optimizing Utilization of Kidneys from Hepatitis C-Positive Kidney Donors.

Authors:  Venkatesh K Ariyamuthu; Bekir Tanriover
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-15       Impact factor: 8.237
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.